Cargando…

Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing

Developing new therapeutics for the treatment of childhood cancer has challenges not usually associated with adult malignancies. Firstly, childhood cancer is rare, with approximately 12,500 new diagnoses annually in the U.S. in children 18 years or younger. With current multimodality treatments, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghilu, Samson, Kurmasheva, Raushan T., Houghton, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038510/
https://www.ncbi.nlm.nih.gov/pubmed/33916592
http://dx.doi.org/10.3390/jcm10071504

Ejemplares similares